title: Morphine, pethidine and buprenorphine disposition in the cat.
abstract: Pharmacokinetics of morphine, buprenorphine and pethidine were determined in 10 cats. Six cats received morphine (0.2 mg/kg) intravenously and four intramuscularly. Five received buprenorphine (0.01 mg/kg) intravenously and six intramuscularly. Six received pethidine (5 mg/kg) intramuscularly. Jugular venous blood samples were collected at time points to 24 h, and plasma morphine concentrations were measured by high performance liquid chromatograpy (HPLC), buprenorphine by radioimmunoassay (RIA) and pethidine by gas chromatography. Our data for morphine show elimination half-life (t1/2el) 76.3 min intravenous (i.v.) and 93.6 min intramuscular (i.m.); mean residence time (MRT) 105.0 and 120.5 min; clearance (Clp) 24.1 and 13.9 mL/kg/min; and volume of distribution (V(dss)) 2.6 and 1.7 L/kg, respectively. Comparable data for buprenorphine are t1/2el 416.8 and 380.2 min; MRT 417.6 and 409.8 min; Clp 16.7 and 23.7 mL/kg/min; and V(dss) 7.1 and 8.9 L/kg. For i.m. pethidine, t1/2el 216.4 min; MRT 307.5 min; Clp 20.8 mL/kg/min and V(dss) 5.2 L/kg. For i.m. dosing, the tmax for morphine, buprenorphine and pethidine were 15, 3 and 10 min, respectively. The pharmacokinetics of the three opioids in cats are broadly comparable with those of the dog, although there is a suggestion that the cat may clear morphine more slowly.
authors.affiliation: Department of Clinical Veterinary Medicine, University of Cambridge, Cambridge, UK. pmt12@cam.ac.uk
authors.forename: P M
authors.initials: PM
authors.lastname: Taylor
authors.forename: S A
authors.initials: SA
authors.lastname: Robertson
authors.forename: M J
authors.initials: MJ
authors.lastname: Dixon
authors.forename: M
authors.initials: M
authors.lastname: Ruprah
authors.forename: J W
authors.initials: JW
authors.lastname: Sear
authors.forename: B D
authors.initials: BD
authors.lastname: Lascelles
authors.forename: C
authors.initials: C
authors.lastname: Waters
authors.forename: M
authors.initials: M
authors.lastname: Bloomfield
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D000818:Animals; D019540:Area Under Curve; D002047:Buprenorphine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002415:Cats / Q000378:metabolism*; D002849:Chromatography, Gas / Q000662:veterinary; D002851:Chromatography, High Pressure Liquid / Q000662:veterinary; D004285:Dogs; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular / Q000662:veterinary; D007275:Injections, Intravenous / Q000662:veterinary; D008614:Meperidine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D009020:Morphine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D011863:Radioimmunoassay / Q000662:veterinary
chemical_list: D000701:Analgesics, Opioid; D002047:Buprenorphine; D009020:Morphine; D008614:Meperidine